Kalos Management, Inc. Amarin Corp Plcuk Transaction History

Kalos Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.13 - $3.69 $451 - $1,476	-400 Reduced 3.56%	10,850 $15,000
Q1 2022 Jun 21, 2022	BUY	$2.85 - $3.73 $32,062 - $41,962	11,250 New	11,250 $37,000
Q4 2021 Feb 03, 2022	SELL	$3.24 - $5.18 $56,538 - $90,391	-17,450 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$3.94 - $5.84 $9,456 - $14,016	2,400 Added 15.95%	17,450 $79,000
Q2 2021 Aug 11, 2021	BUY	$4.26 - $6.5 $20,235 - $30,875	4,750 Added 46.12%	15,050 $68,000
Q1 2021 May 13, 2021	SELL	$5.03 - $8.8 $27,413 - $47,960	-5,450 Reduced 34.6%	10,300 $47,000
Q4 2020 Feb 11, 2021	SELL	$4.04 - $5.31 $9,292 - $12,213	-2,300 Reduced 12.74%	15,750 $77,000
Q3 2020 Nov 12, 2020	SELL	$3.64 - $7.76 $12,922 - $27,548	-3,550 Reduced 16.44%	18,050 $83,000
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $32,743 - $56,581	6,850 Added 46.44%	21,600 $149,000
Q1 2020 May 13, 2020	SELL	$4.0 - $21.53 $10,800 - $58,131	-2,700 Reduced 15.47%	14,750 $61,000
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $243,253 - $420,894	17,450 New	17,450 $374,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.